Trails Edge Capital Partners, LP - Aug 29, 2025 SCHEDULE 13G Report for vTv Therapeutics Inc. Common Stock, par value $0.01 per share (VTVT)

Filing Manager
Trails Edge Capital Partners, LP
Reporting Manager
Trails Edge Capital Partners, LP
Security
vTv Therapeutics Inc. Common Stock, par value $0.01 per share
Symbol
VTVT
Shares outstanding
3.44M shares
Disclosed Ownership
341K shares
Ownership
9.9%
Form type
SCHEDULE 13G
Date filed
9/8/2025, 06:00 PM
Date of event
Aug 29, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Trails Edge Capital Partners, LP 9.9% 341K 341K 0 By: Trails Edge Capital Partners, LLC, GP of Trails Edge Capital Partners, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge Capital Partners, LLC
Trails Edge Biotechnology Master Fund, LP 9.9% 341K 341K 0 By: Trails Edge GP, LLC, GP of Trails Edge Biotechnology Fund GP, LP, GP of Trails Edge Biotechnology Master Fund, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge GP, LLC
Ortav Yehudai 9.9% 341K 341K 0 /s/ Ortav Yehudai Ortav Yehudai / Individual